Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-07-02 | D/A | $37.5M | 16 | |
| 2026-10-02 | D/A | $65.3M | 42 | +$27.8M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor. All Innovahealth vehicles →
Sold rose to $NaN (+$27.8M, +26 investors) in 457 days since the previous filing.
INNOVAHEALTH PARTNERS (INNOVAHEALTH PARTNERS, LP)
Website and main-office phone from Form ADV. Subscribe to unlock
Schedule D for this adviser has not been read yet; it is queued.
1 other filing on EDGAR under this adviser, with size, strategy and date. Subscribe to unlock
| MORTIMER BERKOWITZ III | Executive Officer |
| JOHN MCCORMICK | Executive Officer |
| ARIELLA GOLOMB | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by JOHN MCCORMICK, MANAGING MEMBER OF THE GENERAL PARTNER.
Relevant to: Fund audit & tax, Fund administrator.
The issuer's phone number and address from the filing are shown to subscribers. See plans.
